Impact of Sperm DNA Integrity on In Vitro Cycles

NCT01232465 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 420

Last updated 2014-04-11

Study results available
· View outcomes & findings →

Summary

Sperm DNA integrity will be measured via the Toluidine Blue Assay (TBA) for patients undergoing In Vitro Fertilization (IVF); the study will determine correlations, if any, between IVF success and sperm DNA integrity.

Conditions

  • Male Infertility
  • Unexplained Infertility
  • Abortion, Habitual

Sponsors & Collaborators

  • Northwell Health

    lead OTHER

Principal Investigators

  • Avner E Hershlag, MD · Center for Human Reproduction

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2013-02-28
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01232465 on ClinicalTrials.gov